
Semler Scientific Hits New 52-Week Low at $17.41 Amid Declining Performance
2025-11-24 16:19:43Semler Scientific, Inc. has hit a new 52-week low, reflecting a difficult year marked by a significant stock price decline. The company, with a market capitalization of approximately USD 425 million, has reported negative financial results for four consecutive quarters, impacting key performance metrics.
Read More
Semler Scientific Hits New 52-Week Low at $18.45 Amid Ongoing Struggles
2025-11-21 15:51:28Semler Scientific, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. The company has reported negative results for four consecutive quarters, with key financial metrics indicating struggling operational performance. Its market capitalization stands at USD 425 million, with no dividends offered.
Read More
Semler Scientific Hits 52-Week Low at $19.54 Amid Ongoing Decline
2025-11-20 16:33:31Semler Scientific, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. The company, with a market capitalization of USD 425 million, has reported negative financial results for four consecutive quarters, impacting key metrics like operating cash flow and net sales.
Read More
Semler Scientific Hits New 52-Week Low at $19.56 Amidst Significant Decline
2025-11-18 16:59:28Semler Scientific, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company, with a market capitalization of USD 425 million, has reported negative results for four consecutive quarters and has low operating cash flow and net sales.
Read More
Semler Scientific Stock Plummets to New 52-Week Low of $21.56
2025-11-17 16:42:24Semler Scientific, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. The company, with a market cap of approximately USD 425 million, has reported negative financial results for four consecutive quarters, including low operating cash flow and net sales.
Read More
Semler Scientific, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape
2025-11-17 15:44:13Semler Scientific, Inc. has recently adjusted its valuation metrics, reporting a P/E ratio of 24 and a price-to-book value of 2.32. Compared to peers like Axogen and Standard BioTools, which face financial challenges, Semler's performance indicators suggest a relatively stable position in a competitive market.
Read More
Semler Scientific Hits 52-Week Low at $21.84 Amid Ongoing Struggles
2025-10-23 17:07:35Semler Scientific, Inc. has hit a new 52-week low, reflecting a significant decline over the past year. The company, with a market capitalization of USD 425 million, has reported negative financial results for four consecutive quarters, with operating cash flow and net sales at their lowest levels.
Read More
Semler Scientific Hits New 52-Week Low at $23.51 Amid Declining Performance
2025-10-14 18:50:49Semler Scientific, Inc. has reached a new 52-week low, reflecting a significant decline in its stock price over the past year. The company has reported negative financial results for four consecutive quarters, with low net sales and operating cash flow, while maintaining a market capitalization of USD 425 million.
Read MoreIs Semler Scientific, Inc. technically bullish or bearish?
2025-09-20 19:26:08As of 19 August 2025, the technical trend for Semler Scientific, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from multiple indicators: both the weekly and monthly MACD are bearish, the monthly RSI is bearish, and daily moving averages also reflect a bearish trend. Additionally, Bollinger Bands and KST are bearish on a monthly basis, while Dow Theory and OBV show a mildly bearish stance on the weekly timeframe. In terms of performance, the stock has underperformed significantly against the S&P 500, with a year-to-date return of -45.39% compared to the S&P 500's 12.22%, and a 3-year return of -26.55% versus the S&P 500's 70.41%....
Read More





